-
CBS News - 1 hour 0 minutes ago
Pharmaceutical Makers Presenting FDA with Risk Management Plans to Curb Misuse of Prescription Painkillers
-
San Francisco Chronicle - 2 hours 7 minutes ago
The swine flu is receding in the Bay Area and nationwide, and the worst of the pandemic may be over, but public health experts say it's too early for people to let their guard down. The number of hospitalizations and deaths from the swine flu probably peaked...
-
Wichita Falls Times Record News - Fri Dec 4, 1:27 am ET
Health officials in Wichita Falls have received their shipment of H1N1 influenza vaccine for Saturday’s vaccination clinic and will provide the vaccines to people who fall into several priority groups.The Wichita Falls-Wichita County Public Health District has received 2,280 doses of the vaccine and will provide them from 8 a.m. to 2 p.m. Saturday at the Ray Clymer Exhibit Hall at the Multi ...
-
Bloomberg via Yahoo! News - Fri Dec 4, 12:01 am ET
Dec. 4 (Bloomberg) -- Abortion, the issue that almost derailed House health-care legislation, emerged anew as a hurdle for the U.S. Senate measure.
-
Washington Post - Fri Dec 4, 12:00 am ET
An economist at the Office of Management and Budget who has battled environmentalists for years on issues such as climate change and smog has raised questions about the economic impact of a proposed new rule on air pollution, according to documents obtained by The Washington Post.
-
Forbes - Thu Dec 3, 6:11 pm ET
Premiums for individuals and small businesses will soar under the Senate health reform bill, an industry-funded study predicts.
-
Zacks.com via Yahoo! Finance - 2 hours 10 minutes ago
The FDA lifted a clinical hold on CytRx's molecular chaperone candidate arimoclomol.
-
New York Times - Thu Dec 3, 11:13 pm ET
The Erie Family Health Center, in the Humboldt Park neighborhood, will not turn patients away, even if they cannot pay.
-
HealthDay via Yahoo! News - Thu Dec 3, 12:02 pm ET
THURSDAY, Dec. 3 (HealthDay News) -- Kalbitor (ecallantide) has been approved by the U.S. Food and Drug Administration to treat dangerous flares of sudden fluid buildup in people with hereditary angiodema (HAE), the agency said.
-
TheStreet.com - 2 hours 22 minutes ago
Despite the FDA's recent rejection of experimental drug Ampligen, Hemispherx's CEO remains optimistic.
-
Reuters via Yahoo! News - Thu Dec 3, 5:20 pm ET
The health insurance industry on Thursday struck back at provisions in Congress' healthcare proposals that it said would do little to curb the nation's spiraling costs or provide people more affordable coverage.
-
Bloomberg - 2 hours 39 minutes ago
Average prices climbed 1.2 percent to 27.9 cents a liter ($1.59 a gallon) from 27.5 cents in September, Dutch farm organization LTO said in a report on its Web site today. Prices were down 22 percent from 35.6 cents a liter a year earlier.
-
Bloomberg - 2 hours 46 minutes ago
Dec. 4 (Bloomberg) -- Shares of the following companies may have unusual moves in U.S. trading . Stock symbols are in parentheses, and prices are as of 9 a.m. in New York.
-
INO News - Thu Dec 3, 1:44 pm ET
Aetna fell $.55 or 1.8 percent, to $29.21. CIGNA fell $.55 or 1.6 percent, to $32.82.
-
Zacks.com via Yahoo! Finance - 2 hours 49 minutes ago
Cephalon filed a patent infringement lawsuit against generic player Teva, which is seeking to market a generic version of Cephalon's sleep franchise product, Nuvigil.